Prothena Corp Public Ltd Co SEC filings PRTA

Prothena Corp Public Ltd Co has 1,006 filings in SEC EDGAR's recent list, going back to Jan 31, 2013. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Prothena Corp Public Ltd Co SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Agreement ended
Oct 29, 2026 Oct 28, 2026
4 Insider transaction Oct 29, 2026 Oct 27, 2026
4 Insider transaction Oct 26, 2026 Oct 22, 2026
4 Insider transaction Oct 15, 2026 Oct 13, 2026
4 Insider transaction Oct 9, 2026 Oct 7, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
8-K Current report
Officer or director change
Oct 2, 2026 Oct 2, 2026
4 Insider transaction Sep 30, 2026 Sep 29, 2026
4 Insider transaction Sep 29, 2026 Sep 28, 2026
4 Insider transaction Sep 21, 2026 Sep 18, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Aug 21, 2026 Aug 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 19, 2026 —
3 Initial insider ownership Aug 18, 2026 Aug 18, 2026
4 Insider transaction Aug 18, 2026 Aug 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 11, 2026 Aug 10, 2026
3 Initial insider ownership Aug 11, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 7, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
144 Notice of proposed sale Jul 29, 2026 —
144 Notice of proposed sale Jul 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2026 —
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
3 Initial insider ownership Jun 12, 2026 Jun 8, 2026
144 Notice of proposed sale Jun 9, 2026 —
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 3, 2026 Jun 2, 2026
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 15, 2026 May 15, 2026
4 Insider transaction May 15, 2026 May 15, 2026
4 Insider transaction May 15, 2026 May 15, 2026
4 Insider transaction May 15, 2026 May 15, 2026
4 Insider transaction May 15, 2026 May 15, 2026
4 Insider transaction May 15, 2026 May 15, 2026
8-K Current report
Shareholder vote results
May 15, 2026 May 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
3 Initial insider ownership May 14, 2026 May 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 11, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
4 Insider transaction Apr 10, 2026 Apr 10, 2026
3 Initial insider ownership Apr 10, 2026 Apr 10, 2026
ARS Annual report to shareholders Mar 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 27, 2026 —
DEF 14A Proxy statement Mar 27, 2026 May 14, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
EFFECT Filing Mar 2, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Feb 27, 2026 Feb 27, 2026
POS AM Filing Feb 27, 2026 —
10-K Annual report Feb 27, 2026 Dec 31, 2025
POSASR Filing Feb 27, 2026 —
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
8-K Current report
Officer or director change
Dec 12, 2025 Dec 10, 2025
8-K Current report
Shareholder vote results
Nov 19, 2025 Nov 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
DEFA14A Additional proxy material Nov 6, 2025 —
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
DEFA14A Additional proxy material Oct 7, 2025 —
DEF 14A Proxy statement Oct 7, 2025 Nov 19, 2025
PRE 14A Preliminary proxy statement Sep 25, 2025 Nov 19, 2025
8-K Current report
Other events
Aug 27, 2025 Aug 27, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
S-8 Employee stock plan registration Aug 8, 2025 —
8-K Current report
Other events
Aug 6, 2025 Aug 6, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 4, 2025 Aug 4, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
8-K Current report
Officer or director change
Jul 30, 2025 Jul 30, 2025
8-K Current report
Exit or restructuring costs, Officer or director change
Jun 18, 2025 Jun 13, 2025
8-K Current report
Other events
Jun 16, 2025 Jun 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jun 4, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 29, 2025 —
8-K Current report
Other events
May 23, 2025 May 23, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 16, 2025 May 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 6, 2025 —
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 2, 2025 Dec 18, 2024
3 Initial insider ownership May 1, 2025 Dec 17, 2024
ARS Annual report to shareholders Mar 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 28, 2025 —
DEF 14A Proxy statement Mar 28, 2025 May 13, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 21, 2025 —
8-K Current report
Results of operations
Feb 20, 2025 Feb 20, 2025
4 Insider transaction Feb 14, 2025 Apr 8, 2020
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 3, 2025 —
8-K Current report
Officer or director change
Dec 30, 2024 Dec 29, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 18, 2024 —
4 Insider transaction Oct 3, 2024 Oct 1, 2024
3 Initial insider ownership Oct 3, 2024 Sep 27, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 27, 2024 Sep 23, 2024
S-8 Employee stock plan registration Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Material agreement, Other events
May 28, 2024 May 24, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 17, 2024 May 14, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Mar 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 29, 2024 —
DEF 14A Proxy statement Mar 29, 2024 May 14, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
3 Initial insider ownership Mar 5, 2024 Mar 1, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
3 Initial insider ownership Feb 23, 2024 Feb 21, 2024
S-3ASR Automatic shelf registration Feb 22, 2024 —
10-K Annual report Feb 22, 2024 Dec 31, 2023
8-K Current report
Officer or director change
Feb 21, 2024 Feb 21, 2024
8-K Current report
Results of operations
Feb 15, 2024 Feb 15, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2024 —
4 Insider transaction Jan 24, 2024 Jan 24, 2024
144 Notice of proposed sale Jan 24, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PRTA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Ireland
Headquarters
Dublin 2, Ireland
SEC filer status
Accelerated filer
SEC CIK
1559053
Former names
Prothena Corp plc (until May 22, 2020); Neotope Corp Ltd (until Oct 1, 2012)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.